Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 7 0
Luteolin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 4 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0
Paritaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 5 0
Cannabidiol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/14/2021 2 0
Isorhamnetin Potential treatment - theoretical effect Natural product Antiviral Dec/30/2020 2 0
Cordycepin Potential treatment - theoretical effect Natural product Antiviral Dec/07/2020 1 0
MPI8 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/07/2020 1 0
Excel (.xslx) CSV (.csv)